Yuyu Pharma Inc Capital Reinvestment Ratio

Latest as of June 2026: 1.12x

Yuyu Pharma Inc capital reinvestment ratio. Yuyu Pharma Inc (000225) has a Capital Reinvestment Ratio of 1.12x as of June 2026, meaning it reinvests 1% of its operating cash flow (₩4.91 Billion) in capital expenditures (₩5.52 Billion). Check Yuyu Pharma Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

1.12x
Capex / Operating Cash Flow

Operating Cash Flow

₩4.91 Billion
KRW

Capital Expenditures

₩5.52 Billion
KRW

Data as of

Jun 2026
Most recent filing

Capital Reinvestment Ratio of Yuyu Pharma Inc (2014–2025)

Capital reinvestment ratio of Yuyu Pharma Inc from 2014 to 2025. This chart tracks Yuyu Pharma Inc's Capital Reinvestment Ratio across 9 annual periods. Also explore Yuyu Pharma Inc (000225) equity growth momentum to track the company's year-over-year net asset growth rate.

Yuyu Pharma Inc Capital Reinvestment Ratio by Year (2014–2025)

Yuyu Pharma Inc capital reinvestment ratio by year from 2014 to 2025. For the full cash flow conversion analysis, see 000225 operating cash flow.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2025 0.53x ₩15.88 Billion ₩8.45 Billion ▲ +81.9%
2024 0.29x ₩24.95 Billion ₩7.30 Billion ▼ -97.6%
2023 12.13x ₩420.86 Million ₩5.11 Billion ▲ +800.7%
2021 1.35x ₩4.51 Billion ₩6.07 Billion ▲ +120.5%
2019 0.61x ₩13.19 Billion ₩8.06 Billion ▼ -61.8%
2018 1.60x ₩6.11 Billion ₩9.76 Billion ▼ -82.7%
2017 9.25x ₩561.35 Million ₩5.19 Billion ▲ +3819.4%
2016 0.24x ₩9.82 Billion ₩2.32 Billion ▼ -20.4%
2014 0.30x ₩1.36 Billion ₩404.37 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow